AtG Therapeutics S.L.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
AtG Therapeutics S.L. - overview
Established
2021
Location
Barcelona, -, Spain
Primary Industry
Biotechnology
About
Based in Barcelona, Spain, and founded in 2021, AtG Therapeutics S. L. is a biotech company that researches and develops methods for combating cancer resistance. Gabriela Valerio, Oriol Casanovas, and Bart Huisken co-founded the company.
As of 2023, the company is led by CEO Itziar Canamasas. In July 2022, AtG Therapeutics raised EUR 556,000 in seed funding from investors Blue Goose Capital, Inveniam, and Women Angels for STEAM. The company engages in finding and advancing therapeutic technologies to address cancer resistance. This includes the development of biomarkers and medications.
They also aid in discovering new targets for cancer therapy, novel drug candidates, and patient selection technologies.
Current Investors
Women Angels for STEAM, Inveniam, Blue Goose Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy
Website
www.atgtx.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
AtG Therapeutics S.L. - timeline of key events
AtG Therapeutics S.L. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.